once daily glp 1 A New Option in Weight Management A new once-daily oral GLP-1, orforglipron (Foundayo™) was FDA approved on April 1, 2026 ATTAIN-1 Trial: ~12.4% average weight loss (~27 lbs) and Improved cholesterol + The Everything Guide to GLP-1s

Established patients who know their protocol: Defy Medical at $99 to $150 per month has a longer track record (founded 2013), broader medication options in certain categories, and lower costs for patients who already know what works for them

We focus on sustainable changes and meeting people where they are. She emphasized that progress matters more than perfection and that long-term success comes from building habits that patients can maintain

More serious risks include pancreatitis, gallbladder disease (cholelithiasis, cholecystitis), diabetic retinopathy complications (particularly with rapid improvement in glucose control), and acute kidney injury due to dehydration from gastrointestinal side effects

Will Wegovy make my IBS symptoms worse